Profile and Prognostic Impact of Multimorbidity in Elderly Patients with Heart Failure: Are there Differences between

Rocío Del Pilar Falcón Fleytas1, Osmar Antonio Centurión2,3, Javier Galeano Figueredo2

  • 1Division of Cardiovascular Medicine. Clinical Hospital. School of Medical Science, Asuncion National University (UNA), Av. Mariscal Lopez y Coronel Cazal, San Lorenzo, Paraguay. rofalconf@hotmail.com.

PubMed

Insights

Elderly women with heart failure (HF) have unique characteristics and better prognoses than men. However, they receive less guideline-recommended treatment, highlighting a need for further research into these disparities.

Area of Science:

  • Cardiology
  • Geriatrics
  • Clinical Research

Background:

  • Heart failure (HF) is a growing concern, particularly in the elderly.
  • Elderly patients, especially women, are underrepresented in clinical trials and registries.
  • Comorbidities in older adults significantly impact HF presentation and outcomes.

Purpose of the Study:

  • To review the specific characteristics of elderly women with heart failure.
  • To investigate disparities in treatment and outcomes compared to men.
  • To identify knowledge gaps regarding HF management in this demographic.

Main Methods:

  • Review of existing clinical trials and registries.
  • Analysis of demographic and clinical data of elderly HF patients.
  • Comparison of treatment patterns and outcomes between sexes.

Main Results:

  • Women with HF are typically older, with more non-cardiovascular comorbidities and preserved ventricular function.
  • Despite a better prognosis (lower hospitalization and mortality), women receive less guideline-recommended therapy.
  • Self-perceived quality of life is worse in women with HF.

Conclusions:

  • Elderly women with HF present differently and have a better prognosis than men.
  • There are significant treatment disparities, with women less likely to receive guideline-recommended interventions.
  • Further research is crucial to understand and address these gaps in evidence and care.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.2K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K